Skip to main content
For US Healthcare Professionals Only
Quick Links
Prescribing Information
BIMZELX® (bimekizumab-bkzx)
BRIVIACT® (brivaracetam) CV
CIMZIA® (certolizumab pegol)
FINTEPLA® (fenfluramine)
NAYZILAM® (midazolam) CIV
RYSTIGGO® (rozanolixizumab-noli)
ZILBRYSQ® (zilucoplan)
Adverse Event Reporting
Report an Adverse Event or Product Complaint
Email
1-844-599-CARE (2273)
Connect With an MSL
Connect With Us
Main navigation
Home
Our Science
Overview
Publications
Clinical Pipeline
Opportunities for Investigators
Disease Education
Overview
Dermatology
Epilepsy
Rare Disease
Rheumatology
Podcasts
Independent Medical Education
Congress Materials
Medical Information
Overview
Submit Medical Inquiry
Slide Library
HCP Resources
Prescribing Information
Connect With an MSL
Connect With Us
BIMZELX® (bimekizumab-bkzx)
BRIVIACT® (brivaracetam) CV
CIMZIA® (certolizumab pegol)
FINTEPLA® (fenfluramine)
NAYZILAM® (midazolam) CIV
RYSTIGGO® (rozanolixizumab-noli)
ZILBRYSQ® (zilucoplan)
Home
Congress Materials
Congress Materials
Academy of Managed Care Pharmacy (AMCP), 2024
Filter
Close
Filter
Content type:
Medical Symposium
Oral Presentation
Poster
Video
Apply filters
Real-World Use and Associated Healthcare Resource Utilization Among Patients With Epilepsy Receiving Rescue Midazolam Nasal Spray
Jeannette Novatski, Hillary Doyle, Amelia Boehme, et al.
Poster
Access Barriers to Antiseizure Medications and Neurologists: Effects on Epilepsy Stakeholder Experiences
Herbert Peeples, Emily Achter, Christopher Dieyi, et al.
Poster
For US Healthcare Professionals Only